Health technology assessment
Public consultation on strengthening EU cooperation on Health Technology Assessment (HTA)
Public health, Internal Market, Industry, Entrepreneurship and SMEs, Research and Innovation
All citizens and organisations are welcome to contribute to this consultation. Contributions are particularly sought from patient organisations, public authorities and government-appointed bodies responsible for commissioning or executing HTA reports, national health insurance and social security institutions and associations representing such bodies, companies developing pharmaceuticals, medical devices and other technologies as well as associations representing these industries, healthcare providers and professional associations, as well as academic institutions.
Period of consultation
From 21/10/2016 to 20/01/2017
Please note that we cannot guarantee to take account of replies received after the deadline.
Health Technology is a term used to cover certain aspects of healthcare products or services, such as:
- Pharmaceuticals (any medicinal products, from simple pain killers and gastro-protectors to anti-cancer medicines)
- Medical devices/equipment (for example X-ray machines, pacemakers, insulin pumps)
- Medical and surgical procedures (for example laparoscopy, hip replacement surgery)
- Other measures for disease prevention, diagnosis or treatment used in healthcare (such as vaccination programmes, pregnancy tests, screening test for early diagnostic of cancers, etc.).
Health technology assessment (HTA) measures the added value of a new health technology in comparison to existing technologies/current standard of care. HTA is defined as a multidisciplinary process that summarises information in a systematic, unbiased and robust manner about the medical, economic, organisational, social and ethical issues related to the use of a health technology. The goal of HTA is to support decision makers at national, regional or local level in their efforts to ensure that patients are treated with the best available treatment while keeping the health budgets under control/in balance. HTA also encourages economic stakeholders to focus their research on areas where they expect significant innovation.
Objective of the consultation
This public consultation aims to gather detailed views and opinions relating to the future of the EU cooperation on HTA, as proposed in the Inception Impact Assessment published by the European Commission (see Reference documents). The results of this public consultation will feed into the impact assessment process which the Commission services are currently preparing on strengthening EU cooperation on HTA.
The strategy for the public consultation is outlined in this document.
How to submit your contribution
We welcome contributions from all stakeholders including citizens, industry and public administrations.
- If you are answering this consultation as a citizen, please click here to submit your contribution. This questionnaire is available in all EU official languages.
- If you are answering this consultation on behalf of any other stakeholder, i.e. public administrations, industry, associations or other organisations, please click here to submit your contribution. This questionnaire is available only in English.
View the questionnaire
You can preview/print a PDF version of the online questionnaire to help you to prepare your response.
Before completing the questionnaire, we invite you to take a look at the Inception Impact Assessment for an EU initiative for strengthening EU cooperation on Health Technology Assessment (HTA).
Other documents you may find useful are:
- EUnetHTA Joint Action 3 (2016-2020)
- Executive Summary Report of EUnetHTA Joint Action 2 (2016 )
- Strategy for EU Cooperation on Health Technology Assessment adopted by the HTA Network (2014)
- Reflection Paper on Reuse of Joint Work in National HTA Activities adopted by the HTA Network (2015)
- Commission Implementing Decision of 26 June 2013 providing the rules for the establishment, management and transparent functioning of the Network of national authorities or bodies responsible for health technology assessment
Responsible service: Directorate-General for Health and Food Safety - Unit B4 Medical products: safety, quality, innovation
Any queries about the public consultation should be sent to this mailbox.
Contributions to and results of the consultation
Received contributions will be published on this webpage, unless respondents choose an anonymised publication of their responses or do not authorise any publication of their responses.
In the interests of transparency, all stakeholders other than citizens and public authorities are invited to provide the public with relevant information about themselves by registering in Transparency Register and subscribing to its Code of Conduct. If the stakeholder is not registered, the submission is published separately from the registered organisations.
The results of the public consultation will be evaluated and an overview will be made available here.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here
Specific privacy statement
Contributions will be published on the Internet. It is important to read the specific privacy statement attached to this consultation for information on how your personal data and contribution will be dealt with.